Health
2nd study testing a COVID-19 antibody drug has a setback – Devdiscourse
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need…
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalised patients. Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need intense oxygen treatment or breathing machines — because of a potential safety problem and unfavourable balance of risks and benefits.
The study can continue to test the two-antibody…
-
Noosa News20 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General14 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Business24 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
Business22 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400